EUVIMEDEUVIMED entdecken
Crossref

Comorbid conditions and survival among Black women with ovarian cancer

Alicia R Richards, Courtney E Johnson iD, Nachalie Ramos Montalvo, Anthony J Alberg, Elisa V Bandera, Melissa Bondy, Lindsay J Collin iD, Michele L Cote iD, Theresa A Hastert, Kristin Haller, Namita Khanna, Jeffrey R Marks und 7 weitere

Cancer · 2025-01 · 131 (1)

DOI: 10.1002/cncr.35694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 02.01.2025. Verfasst von Alicia R Richards und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Black or African American, Carcinoma, Ovarian Epithelial, Comorbidity, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Black women with epithelial ovarian cancer (EOC) have worse survival and a higher burden of comorbid conditions compared with other racial groups. This study examines the association of comorbid conditions and medication use for these conditions with survival among Black women with EOC.

Methods

In a prospective study of 592 Black women with EOC, the Charlson comorbidity index (CCI) based on self‐reported data, three cardiometabolic comorbidities (type 2 diabetes, hypertension, and hyperlipidemia), and medication use for each cardiometabolic comorbidity were evaluated. Cox proportional hazards regression models were used to examine the association of comorbid conditions and related medication use with all‐cause mortality while adjusting for relevant covariates overall and by histotype (high‐grade serous [HGS]/carcinosarcoma vs. non‐HGS/carcinosarcoma) and stage (I/II vs. III/IV).

Results

A CCI of ≥2 was observed in 42% of the cohort, and 21%, 67%, and 34% of women had a history of type 2 diabetes, hypertension, and hyperlipidemia, respectively. After adjusting for prognostic factors, a CCI ≥2 (vs. 0; hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.04–1.71) and type 2 diabetes (HR, 1.42; 95% CI, 1.10–1.84) were associated with an increased risk of mortality. The increased risk of mortality for type 2 diabetes was present specifically among women with HGS/carcinosarcoma (HR, 1.47; 95% CI, 1.10–1.97) and among women with stage III/IV disease (HR, 1.47; 95% CI, 1.10–1.98). The authors did not find evidence that hypertension, hyperlipidemia, or medication use for the cardiometabolic comorbidities meaningfully impacted survival.

Conclusion

Comorbid conditions, especially type 2 diabetes, had a significant adverse impact on survival among Black women with EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanCarcinoma, Ovarian EpithelialComorbidityDiabetes Mellitus, Type 2HyperlipidemiasHypertensionOvarian NeoplasmsAdultAgedFemaleHumansMiddle AgedCarcinosarcomaPrognosisProportional Hazards ModelsProspective Studies

Stichwörter der Autor:innen

Charlson comorbidity indexcomorbidityovarian cancersurvival

Autor:innen und Institutionen

  • Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
  • University of South Florida College of Public Health, Tampa, Florida, USA.
  • Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA.
  • Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, New Jersey, USA.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Los Angeles, California, USA.

ORCID-Profile: Courtney E Johnson, Lindsay J Collin, Michele L Cote, Paul D Terry, Joellen M Schildkraut, Lauren C Peres

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Richards, A. R., Johnson, C. E., Montalvo, N. R., Alberg, A. J., Bandera, E. V., Bondy, M., Collin, L. J., Cote, M. L., Hastert, T. A., Haller, K., Khanna, N., Marks, J. R., Peters, E. S., Qin, B., Staples, J., Terry, P. D., Lawson, A., Schildkraut, J. M., & Peres, L. C. (2025). Comorbid conditions and survival among Black women with ovarian cancer. Cancer, 131(1). https://doi.org/10.1002/cncr.35694

Vancouver

Richards AR, Johnson CE, Montalvo NR, Alberg AJ, Bandera EV, Bondy M, et al. Comorbid conditions and survival among Black women with ovarian cancer. Cancer. 2025;131(1). doi:10.1002/cncr.35694

BibTeX
@article{Richards2025,
  author = {Richards, Alicia R and Johnson, Courtney E and Montalvo, Nachalie Ramos and Alberg, Anthony J and Bandera, Elisa V and Bondy, Melissa and Collin, Lindsay J and Cote, Michele L and Hastert, Theresa A and Haller, Kristin and Khanna, Namita and Marks, Jeffrey R and Peters, Edward S and Qin, Bo and Staples, Jeanine and Terry, Paul D and Lawson, Andrew and Schildkraut, Joellen M and Peres, Lauren C},
  title = {Comorbid conditions and survival among Black women with ovarian cancer},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {1},
  doi = {10.1002/cncr.35694}
}
Kostenlos starten →